The impact of calcineurin inhibitors and mammalian target of rapamycininhibitors on anxiety and depression scores in kidney transplant patients
Yazarlar (7)
Ebru Gök Oğuz
Ankara Yıldırım Beyazıt Üniversitesi
Ankara Yıldırım Beyazıt Üniversitesi
Gülay Ulusal Okyay Ankara Yıldırım Beyazıt Üniversitesi
Güner Karaveli Gürsoy
Ankara Yıldırım Beyazıt Üniversitesi
Ankara Yıldırım Beyazıt Üniversitesi
Prof. Dr. Zafer Ercan Ankara Yıldırım Beyazıt Üniversitesi
Özgür Merhametsiz Ankara Yıldırım Beyazıt Üniversitesi
Prof. Dr. Başol CANBAKAN Kafkas Üniversitesi, Türkiye
Mehmet Deniz Aylı Sağlık Bilimleri Üniversitesi, Türkiye
| Makale Türü |
Özgün Makale
(SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
|
||
| Dergi Adı | TURKISH JOURNAL OF MEDICAL SCIENCES | ||
| Dergi ISSN | 1300-0144 Wos Dergi Scopus Dergi | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | İngilizce | Basım Tarihi | 01-2016 |
| Kabul Tarihi | – | Yayınlanma Tarihi | 01-01-2016 |
| Cilt / Sayı / Sayfa | 46 / 5 / 1341–1347 | DOI | 10.3906/sag-1506-153 |
| Makale Linki | http://online.journals.tubitak.gov.tr/openDoiPdf.htm?mKodu=sag-1506-153 | ||
| UAK Araştırma Alanları |
İç Hastalıkları
|
||
| Özet |
Background/aimDepression and anxiety are prevalent symptoms in kidney transplant patients. We aimed to evaluate the frequency and the severity of depression and anxiety symptoms in kidney transplant recipients using the Beck Depression Inventory (BDI) and Beck Anxiety Inventory (BAI). The data were compared between the patients on CNI-based and mTORi-based maintenance immunosuppressive regimens.Materials and methodsA total of 94 kidney transplant patients were enrolled in the study after exclusion of the patients already taking neuropsychiatric medications or unwilling to participate in the study. Participants were asked to self-report the inventories.ResultsAnalysis of data showed that 62 (66%) recipients had BDI scores that indicated depression. The patients on CNI-based regimens (n = 74) had increased total BDI scores compared those on mTORi-based regimens [18 (8.75-28) vs. 6 (5.25-14.25), respectively, P < 0.001]. Regarding BAI scores, 79 patients (84%) had prominent anxiety symptoms. The patients on CNI-based regimens had significantly increased total BAI scores compared to those on mTORi-based regimens [21 (13-30.50) vs. 10.50 (8.25-14.75), respectively, P < 0.001].ConclusionOur results identified fewer side effects of mTORi-based maintenance immunosuppressive regimens regarding depression and anxiety symptoms compared to CNI-based regimens in kidney transplant patients. |
| Anahtar Kelimeler |
BM Sürdürülebilir Kalkınma Amaçları
| Atıf Sayıları |